Selective serotonin-reuptake inhibitors for the treatment of hot flashes

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1293-6. doi: 10.1345/aph.1D512. Epub 2004 Jun 8.

Abstract

Objective: To review the literature evaluating the use of selective serotonin-reuptake inhibitors (SSRIs) for the treatment of hot flashes.

Data sources: Biomedical literature was accessed through MEDLINE (1966-June 2003), MD Consult, and references of reviewed articles. Key search terms used were hot flashes, vasomotor symptoms, antidepressants, and SSRIs.

Data synthesis: Recent evidence from the Women's Health Initiative precludes the use of traditional hormonal therapy in some women. Nonhormonal therapies are possible options, but conflicting evidence of efficacy exists.

Conclusions: Although further studies are warranted, preliminary data suggest that SSRIs are generally modestly successful in reducing the frequency and severity of hot flashes.

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic
  • Female
  • Hot Flashes / drug therapy*
  • Humans
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*

Substances

  • Serotonin Uptake Inhibitors